IDEAYA Biosciences, Inc. <IDYA.O>: Truist Securities cuts target price to $59 from $63
IDYA•Related News
SolarEdge Announces Second Quarter 2026 Financial Results
SEDG•
New York Times Co Outlook Q3 Digital-Only Subscription Revenues Increase 12% - 15%
NYT•
Criteo - Sarah Glickman To Step Down As CFO, Remain As Advisor Through September
CRTO•
BioCryst Pharmaceuticals, - Cash, Cash Equivalents, Restricted Cash And Investments $354 Million At June 30, 2026
BCRX•
Icahn Enterprises Q2 net loss widens, net asset value falls
IEP•